Comparing Alpha Teknova (TKNO) & Its Competitors

Alpha Teknova (NASDAQ:TKNO) is one of 109 publicly-traded companies in the “Life Sciences Tools & Services” industry, but how does it weigh in compared to its competitors? We will compare Alpha Teknova to similar businesses based on the strength of its dividends, institutional ownership, earnings, risk, analyst recommendations, profitability and valuation.

Valuation and Earnings

This table compares Alpha Teknova and its competitors revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Alpha Teknova	$40.52 million	-$17.26 million	-23.68
Alpha Teknova Competitors	$2.26 billion	$55.88 billion	-13.90

Alpha Teknova’s competitors have higher revenue and earnings than Alpha Teknova. Alpha Teknova is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Risk and Volatility

Alpha Teknova has a beta of 0.96, indicating that its share price is 4% less volatile than the S&P 500. Comparatively, Alpha Teknova’s competitors have a beta of 0.94, indicating that their average share price is 6% less volatile than the S&P 500.

Institutional and Insider Ownership

13.8% of Alpha Teknova shares are held by institutional investors. Comparatively, 54.4% of shares of all “Life Sciences Tools & Services” companies are held by institutional investors. 13.2% of Alpha Teknova shares are held by insiders. Comparatively, 15.2% of shares of all “Life Sciences Tools & Services” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Alpha Teknova and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Alpha Teknova	-38.37%	-24.94%	-16.53%
Alpha Teknova Competitors	-540.59%	-166.46%	-13.58%

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Alpha Teknova and its competitors, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Teknova	1	1	4	0	2.50
Alpha Teknova Competitors	947	3161	5475	177	2.50

Alpha Teknova currently has a consensus price target of $8.75, indicating a potential upside of 19.21%. As a group, “Life Sciences Tools & Services” companies have a potential downside of 3.79%. Given Alpha Teknova’s higher possible upside, research analysts clearly believe Alpha Teknova is more favorable than its competitors.

Summary

Alpha Teknova competitors beat Alpha Teknova on 8 of the 13 factors compared.

About Alpha Teknova

Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.